Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 Jun;36(3):1023-7.
doi: 10.1128/iai.36.3.1023-1027.1982.

Oxidant-mediated damage of Leishmania donovani promastigotes

Oxidant-mediated damage of Leishmania donovani promastigotes

N E Reiner et al. Infect Immun. 1982 Jun.

Abstract

Dissemination of Leishmania within the host is related to parasites undergoing unchecked proliferation. We therefore studied the effects of oxidant generating systems on promastigote multiplication by (i) direct determinations of organism proliferation and (ii) the incorporation of [3H]uracil into promastigote nucleoprotein. These two parameters correlated closely as measures of organism replication as demonstrated by parallel suppression of them by the protein synthesis inhibitors puromycin and cycloheximide and the nucleic acid synthesis inhibitors actinomycin D and mitomycin C. Promastigotes showed dose-related susceptibility to reagent and generated hydrogen peroxide (H2O2) as reflected in quantitatively similar decreases in multiplication and [3H]uracil incorporation. These effects were specific for H2O2 as catalase abrogated the dimunition in multiplication. The generation of superoxide anion by acetaldehyde-xanthine oxidase (10 mU/ml) did not alter promastigote replication or nucleoprotein synthesis. These results indicate that Leishmania donovani promastigotes are damaged by H2O2 and that the incorporation of [3H]uracil into promastigote nucleoprotein may be useful for studying the interaction of this parasite with host effector cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Adv Immunol. 1971;13:209-66 - PubMed
    1. J Exp Med. 1972 Nov 1;136(5):1173-94 - PubMed
    1. J Clin Invest. 1973 Mar;52(3):741-4 - PubMed
    1. J Clin Invest. 1975 May;55(5):945-55 - PubMed
    1. J Exp Med. 1976 Jun 1;143(6):1402-20 - PubMed

Publication types